Lemme GLP-1 Daily Review: What It Does and Doesn't Do (and the EU Alternative)

Last checked: June 2026. Prices and formulations may change.

Lemme — Kourtney Kardashian's supplement brand — sells "GLP-1 Daily", a capsule that promises to raise your body's own GLP-1 as a natural alternative to medication. The product is hugely visible on social media. But what does it actually do — and is it relevant if you're already on Ozempic, Wegovy or Mounjaro?

What's inside Lemme GLP-1 Daily

Three patented plant extracts: Eriomin (lemon flavonoids), Morosil (red orange) and Supresa (saffron). Price: $80 one-time or $64 with a subscription.

What you should know about the claims

In the US and Canada, class-action lawsuits are challenging the central claim — that raising your own GLP-1 leads to meaningful weight loss. Your body's natural GLP-1 is broken down within minutes; GLP-1 medications work precisely because they are engineered to bypass that breakdown. The outcome of those cases is still open, but the difference with medication is fundamental.

The key question: who is it for?

Lemme GLP-1 Daily is positioned for people who are not on medication. If you already use a GLP-1 medication, it doesn't solve your actual challenge: you're eating 30–50% less, which means less protein, fewer vitamins and minerals — exactly when your body is working hard. That shows up as hair loss, fatigue and muscle loss.

The comparison

Mayntain DailyLemme GLP-1 Daily
PurposeNutritional support ALONGSIDE GLP-1 medication"Natural GLP-1 boost" without medication
Vitamins & minerals✓ D3, B12, biotin, zinc, magnesium
Fibre & gut support✓ Psyllium + Akkermansia
Price per month€38–44$64–80 + import to EU
Claims riskEU-compliant health claimsClaims being legally challenged in the US

On GLP-1 medication and looking for support that actually fits? Discover Mayntain Daily — made in Europe, eight ingredients, every dose on the label.

Food supplements are not a substitute for a varied diet, a healthy lifestyle or medical advice. All brand names are property of their respective owners; information based on public sources (June 2026).

Back to blog